Marijo Bilusic, MD, PhD, Author at Grand Rounds in Urology

Marijo Bilusic, MD, PhD

University of Miami Miller School of Medicine

Miami, Florida

Marijo Bilusic, MD, PhD, is Professor of Clinical Medicine at the University of Miami Miller School of Medicine and a genitourinary medical oncologist at Sylvester Comprehensive Cancer Center in Miami, Florida. He serves as the Genitourinary Medical Oncology Team Lead and specializes in the treatment of genitourinary malignancies including prostate, kidney, bladder, testicular, and adrenal cancers. His research focuses on tumor immunology and the development of novel immunotherapy strategies for prostate cancer and other genitourinary tumors, including therapeutic cancer vaccines, antibodies, immune modulators, and immune checkpoint inhibitors.

Dr. Bilusic earned his medical degree from the University of Zagreb School of Medicine and his PhD from the University of Split School of Medicine in Croatia. He completed a postdoctoral research fellowship in physiological genomics at the Medical College of Wisconsin and a fellowship in hematology and medical oncology at the National Cancer Institute and National Heart, Lung, and Blood Institute. Before joining the University of Miami in 2021, he served at Fox Chase Cancer Center and the National Cancer Institute's Genitourinary Malignancy Branch. At the National Institutes of Health, he also served as Associate Program Director and later as Program Director of the NIH Hematology-Oncology Fellowship Program. Dr. Bilusic is board-certified in medical oncology, hematology, and internal medicine.

Talks by Marijo Bilusic, MD, PhD

Are We Overusing Combination Therapy in mHSPC?

Marijo Bilusic, MD, PhD | Sep 2026

Dr. Marijo Bilusic reviews current evidence supporting treatment intensification in metastatic hormone-sensitive prostate cancer, discussing doublet versus triplet therapy, biomarker-driven treatment selection, and the challenges of applying clinical trial evidence in everyday practice.